Our purpose is to solve the toughest problems in life science by collaborating with the global scientific community – and through that, we aim to accelerate access to better health for people everywhere. We provide scientists and engineers with best-in-class lab materials, technologies, and services. With the 2015 combination of EMD Millipore and Sigma-Aldrich, we now have a broad portfolio of 300,000 products, an expanded global footprint, and an industry-leading eCommerce platform. To learn more, visit https://www.emdmillipore.com/US/en

Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform’s platform technologies. The company focuses on reducing clinical attrition and on enhancing drug molecules’ performance through its nanoforming technologies and formulation services. Nanoform’s capabilities include GMP manufacturing, and its services span the small to large molecule development space with a focus on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications. For more information please visit www.nanoform.com

Care Access is a community-centric clinical research organization accelerating the availability of new medicines and treatments by breaking down traditional barriers in clinical research for patients, sponsors, and physicians. Our innovative model brings a nationwide network of sites, decentralized trials, Sites On Demand™, Virtual PIs, and Mobile Sites to previously- unreachable patient populations to expand the impact of clinical research. To learn more, please visit www.careaccess.com

NOF CORPORATION is the leading commercial supplier of drug delivery products such as activated PEGs, lipids and ultrapure Polysorbates 80. Our cutting edge products include Pendant type single molecule PEG linkers for ADCs and SS-lipids for nucleic acid and gene delivery. For more information, visit www.nofamerica.com

Clincierge is a leading provider of clinical trial patient concierge services responsible for the logistics involved with transporting trial patients to clinical sites for their visits. These logistics include but are not limited to air travel, ground transportation, hotel reservations, and patient reimbursements. To learn more, please visit www.clincierge.com

Oakwood Labs specializes in the development and aseptic manufacturing of sustained-release microsphere products, ranging in duration from weeks to one year, through the use of our patented Chroniject™ technology. Oakwood’s FDA approved cGMP aseptic facility enables partners the ability to bring products from feasibility concepts to successful commercialization. To learn more, visit https://oakwoodlabs.com/

Patient recruitment solutions strategically planned, expertly deployed, and meticulously managed from start to finish. That’s what we’re all about at Clinical Trial Media – or simply, CTM. CTM is a data-driven, global patient recruitment and retention company with a comprehensive suite of innovative technology solutions and patient-centric services, expertly tested and proven across over 2,000 studies in the past 27 years. For more information, go to www.clinicaltrialmedia.com

GENINVO is the go-to partner for life science industry. We deliver innovative software solutions and services to enable our Life Science clients with speed and efficiency in the drug development process. Our global market presence is across UK/Europe, USA & India. Our vision is the digitalization of the pharmaceutical industry. To learn more, please visit https://geninvo.com/

Paragon Medical serves as your strategic partner in medical device manufacturing, offering an end-to-end supply chain solution from product development, to verification and validation testing, to final production, assembly, and ongoing strategic demand planning. Discover how you can experience a consistently remarkable partnership through Paragon Medical’s differentiated and personalized solutions. To learn more, please visit www.paragonmedical.com

Founded in 2020, JNPMEDI is an end-to-end clinical trial solutions provider that develops and services value centered digital tools to clinical research and trial stakeholders. With an entirely in-house developed and built Maven CDMS™ and Maven clinical cloud solutions, JNPMEDI is taking steps forward to digitally transform the capabilities of regulatory authority, pharmaceuticals and CROs for better execution, management, monitoring, and audit of clinical trials. To learn more visit: https://www.jnpmedi.com

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more information, visit www.pfizer.com

Phillips-Medisize, a CDMO of drug delivery, diagnostic and medtech devices, provides innovative products and strategy, design, development and manufacturing services to the global industries. We offer complete end-to-end capabilities from early device strategy through design and development, human factors engineering, clinical production to full scale production, including drug handling and finishing. We have a particular focus on drug delivery devices and connected health, and played an integral role in the first FDA approval for a fully connected drug delivery device, with a regulated companion digital service. Based on our track record of device development and manufacture, and responding to market requirements, we have increased our focus on developing platform-based drug delivery devices. These target the markets need for flexible, cost effective, timely solutions that meet both the industries needs and those of the patient. Our platforms include a smart autoinjector, wearable bolus and a large volume injector and a Mini-tablet Dispenser. For more information, visit www.phillipsmedisize.com.